Page 1387 - Clinical Small Animal Internal Medicine

149 Mammary Cancer 1325

Further Reading
VetBooks.ir Abadie J, Nguyen F, Loussouarn D, et al. Canine invasive treatment of feline mammary carcinoma. J Vet Intern

mammary carcinomas as models of human breast
Med 2009; 23(1): 123–9.
cancer. Part 2: immunophenotypes and prognostic Nguyen F, Peña L, Ibisch C, et al. Canine invasive
significance. Breast Cancer Res Treat 2018; 167(2): mammary carcinomas as models of human breast
459–68. cancer. Part 1: natural history and prognostic factors.
Carvalho MI, Silva‐Carvalho R, Pires I, et al. A Breast Cancer Res Treat 2018; 167(3): 635–48.
comparative approach to tumor‐associated Rasotto R, Berlato D, Goldschmidt, Zappulli V. Prognostic
inflammation in mammary cancer between humans and significance of canine mammary tumor histologic
dogs. Biomed Res Int 2016; 2016: 4917387. subtypes: an observational cohort study of 229 cases. Vet
Kristiansen VM, Peña L, Díez Córdova, et al. Effect of Pathol 2017; 54(4): 571–8.
ovariohysterectomy at the time of tumor removal in Simon D, Schoenrock D, Baumgartner W, Nolte I. Post‐
dogs with mammary carcinomas: a randomized operative adjuvant treatment of invasive malignant
controlled trial. J Vet Intern Med 2016; 30(1): 230–41. mammary gland tumors in dogs with doxorubicin and
McNeill CJ, Sorenmo KU, Shofer SF, et al. Evaluation of docetaxel. J Vet Intern Med 2006; 29(5): 1184–90.
adjuvant doxorubicin‐based chemotherapy for the